CHARLES RIV LAB INT (RV6.SG) (RV6 STU) stock market data APIs
€148.26
0.56(0.4%)
as of February 12, 2025
CHARLES RIV LAB INT (RV6.SG) Financial Data Overview
There is no Profile data available for RV6.SG.
Prev. Close
147.33
Open
148.26
High
148.41
Low
147.7
52 wk Range
147.7-251.9
Market Cap
16 130 M
Shares Outstanding
0
Revenue
0
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get CHARLES RIV LAB INT (RV6.SG) data using free add-ons & libraries
Get CHARLES RIV LAB INT (RV6.SG) Fundamental Data
CHARLES RIV LAB INT (RV6.SG) Fundamental data includes:
- Net Revenue: 0
- EBITDA: 0
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-02-12
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
CHARLES RIV LAB INT (RV6.SG) News
New
Charles River Laboratories (CRL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Charles River Laboratories (CRL) is expected to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended December 2024. This widely-known consensus...
Charles River Laboratories International, Inc. (CRL) Expands AI-Powered Digital Pathology Collaboration with Deciphex
We recently compiled a list of the 10 AI News Updates on Wall Street's Radar.In this article, we are going to take a look at where Charles River Laboratories International, Inc. (NYSE:CRL) stands agai...
Charles River and Deciphex Extend Global Partnership to Expand Digital Pathology Offering with Exclusive Image Management Solutions
WILMINGTON, Mass. & DUBLIN, February 11, 2025--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) and Deciphex, a leader in AI-powered digital pathology, today announced the n...
Are Investors Undervaluing Charles River Laboratories International, Inc. (NYSE:CRL) By 39%?
Key Insights The projected fair value for Charles River Laboratories International is US$269 based on 2 Stage Free Cash Flow to Equity Current share price of US$164 suggests Charles River Laboratorie...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
